BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sumida Y, Eguchi Y, Ono M. Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. World J Hepatol 2010; 2(10): 374-383 [PMID: 21160946 DOI: 10.4254/wjh.v2.i10.374]
URL: https://www.wjgnet.com/1007-9327/full/v2/i10/374.htm
Number Citing Articles
1
Yoshio Sumida, Yuji Naito, Etsuko Hashimoto, Wataru Aoi, Yutaka Takahashi, Yoshikazu Yonei, Toshikazu Yoshikawa. Science of Nonalcoholic Fatty Liver Disease in Anti-Aging Medicine 2011ANTI-AGING MEDICINE 2012; 9(1): 24 doi: 10.3793/jaam.9.24
2
Yoshio Sumida, Toshihide Shima, Yasuhide Mitsumoto, Takafumi Katayama, Atsushi Umemura, Kanji Yamaguchi, Yoshito Itoh, Masashi Yoneda, Takeshi Okanoue. Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in JapanInternational Journal of Molecular Sciences 2020; 21(12): 4337 doi: 10.3390/ijms21124337
3
Carolin Lackner. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist’s perspectiveExpert Review of Gastroenterology & Hepatology 2011; 5(2): 223 doi: 10.1586/egh.11.8
4
Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang. Blood-Based Novel Biomarkers for Nonalcoholic SteatohepatitisBiomarkers in Medicine 2018; 12(5): 501 doi: 10.2217/bmm-2017-0361
5
Norio Akuta, Fumitaka Suzuki, Miharu Hirakawa, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapyJournal of Medical Virology 2011; 83(6): 1016 doi: 10.1002/jmv.22094
6
Erika Wichro, Tanja Macheiner, Jasmin Schmid, Barbara Kavsek, Karine Sargsyan. The Wide and Complex Field of NAFLD Biomarker Research: TrendsISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/846923
7
Carolin Lackner. PathologiePathologie 2020; : 159 doi: 10.1007/978-3-642-04557-8_6
8
Keiko Korenaga, Masaaki Korenaga, Fusako Teramoto, Toshiko Suzuki, Sohji Nishina, Kyo Sasaki, Yoshihiro Nakashima, Yasuyuki Tomiyama, Naoko Yoshioka, Yuichi Hara, Takuya Moriya, Keisuke Hino. Clinical usefulness of non‐protein respiratory quotient measurement in non‐alcoholic fatty liver diseaseHepatology Research 2013; 43(12): 1284 doi: 10.1111/hepr.12095
9
Xiaolin Liu, Yongfeng Wang, Yanan Ming, Yanyan Song, Jingyi Zhang, Xiaoyu Chen, Minde Zeng, Yimin Mao, Hervé Guillou. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic SteatohepatitisPLOS ONE 2015; 10(5): e0127352 doi: 10.1371/journal.pone.0127352
10
Hüseyin Saadettin Uslusoy, Selim Giray Nak, Macit Gülten. Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitisWorld Journal of Hepatology 2011; 3(8): 219-227 doi: 10.4254/wjh.v3.i8.219
11
Xiao Lin Liu, Hai Xia Cao, Jian Gao Fan. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver diseaseJournal of Digestive Diseases 2016; 17(11): 708 doi: 10.1111/1751-2980.12408